What do U.S. Stem Cell’s Risk Factors Tell Investors?
July 21 2021 - 07:01AM
TipRanks
Biotechnology company U.S. Stem Cell, Inc. (USRM) is focused on
bringing to market autologous cellular therapies to treat heart
damage, and vascular and autoimmune diseases. Its business is
focused on developing cell therapy products, along with the sale of
test kits and equipment, training services, laboratory services,
and cell banking. The company’s strategy is to expand revenue from
enterprises such as training services and animal health products
and reinvest these profits into the development of its clinical
pipeline. Let’s take a look at the financial performance of the
company and what’s changed in its key risk factors that investors
should know. On the back of higher product sales, U.S.
https://www.tipranks.com/news/what-do-u-s-stem-cells-risk-factors-tell-investors?utm_source=advfn.com&utm_medium=referral
US Stem Cell (PK) (USOTC:USRM)
Historical Stock Chart
From Jul 2022 to Aug 2022
US Stem Cell (PK) (USOTC:USRM)
Historical Stock Chart
From Aug 2021 to Aug 2022